Richard Jones
Chief Executive Officer at AdrenoMed AG
Profile
Richard Jones currently works at AdrenoMed AG, as Chief Executive Officer from 2022.
Dr. Jones also formerly worked at Fusion Antibodies Plc, as Chief Executive Officer & Director from 2021 to 2022, Akinion Pharmaceuticals AB, as Chief Executive Officer, BrYet Ltd., as Chief Executive Officer & Director in 2020, Holostem Terapie Avanzate S R L, as Chief Executive Officer, Genzyme Corp., as Director-Oncology & Transplant Portfolio, GSK Plc, as Vice President-Global Commercial Leader, Novartis UK Ltd., as VP-Medicines Commercialization, and Akcea Therapeutics UK Ltd., as Senior Vice President & Head-Europe.
Dr. Jones received his undergraduate degree and doctorate degree from the University of Surrey.
Richard Jones active positions
| Companies | Position | Start |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Chief Executive Officer | 2022-03-14 |
Former positions of Richard Jones
| Companies | Position | End |
|---|---|---|
| FUSION ANTIBODIES PLC | Chief Executive Officer | 2022-03-10 |
| BrYet Ltd. | Chief Executive Officer | 2020-06-30 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - |
Training of Richard Jones
| University of Surrey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| FUSION ANTIBODIES PLC | Health Services |
| Private companies | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
| Akcea Therapeutics UK Ltd. | |
| BrYet Ltd. | |
| Holostem Terapie Avanzate S R L | |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Richard Jones